Skip to content
Shelter Pharma logo

Shelter Pharma

543963 BSE
₹49.00

Close ·

View as Markdown
MCP
Close 4 Nov 2026 ₹49.00 +8.16 +20.0% 1Y
Start ₹40.84

Key Fundamentals

SMEPharmaceuticals & BiotechnologyHealthcare

Price-based figures at the close · TTM

ROCE
20.40%
Debt to Equity
0.01
EPS (TTM)
—
Book Value
₹43.16
Market Cap
—
P/E (TTM)
—
P/B
1.14
ROE
15.10%
Dividend Yield
0.75%
EBITDA
₹12.70 Cr
52W High
₹55.88
52W Low
₹23.00

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

66 Strong

Data confidence 84/100

Category scores

Quality
67
Strong
Returns, margins, earnings quality 22% weight
Valuation
49
Average
Cheap vs sector & own history 24% weight
Growth
89
Strong
Sales & profit trajectory 9% weight
Financial Health
84
Strong
Solvency, leverage, coverage 9% weight
Momentum
99
Strong
Trend strength, vol-adjusted 12% weight
Ownership
58
Good
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 1.00 times its book value

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last 3 years: -12.3%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish3412
OscillatorsBearish342
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
63.59
Neutral
MACD (12,26,9)
1.83
Bearish
SMA (50)
38.60
Bullish
SMA (200)
33.65
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
10Y+10.02%
5Y+26.57%
3Y+26.41%
1Y+44.19%

Net profit

Net profit growth by window
10Y+68.14%
5Y+195.61%
3Y+20.12%
1Y+24.72%

Operating cash flow

Operating cash flow growth by window
10Y—
5YOutflow widened by ₹12.20 Cr
3YTurned negative
1YTurned negative

10Y: The statements do not go back far enough for this window.

Operating margin· change in pp

Operating margin growth by window
10Y+16.90 pp
5Y+16.58 pp
3Y−5.11 pp
1Y−2.46 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2016₹28.09 Cr
Mar 2017₹29.95 Cr
Mar 2020₹30.07 Cr
Mar 2021₹22.48 Cr
Mar 2022₹30.06 Cr
Mar 2023₹36.15 Cr
Mar 2024₹39.93 Cr
Mar 2025₹50.64 Cr
Mar 2026₹73.02 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2016₹0.05 Cr
Mar 2017₹0.05 Cr
Mar 2020₹0.08 Cr
Mar 2021₹0.04 Cr
Mar 2022₹2.06 Cr
Mar 2023₹5.21 Cr
Mar 2024₹6.20 Cr
Mar 2025₹7.24 Cr
Mar 2026₹9.03 Cr

Half-yearly Results

₹ Cr
543963 half-yearly results, ₹ crore
Particulars Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
17.02
19.13
19.31
20.71
24.06
26.6
33.29
39.84
Expenses
13.71
14.82
15.02
16.42
19.16
21.42
27.03
33.37
Operating Profit
3.31
4.31
4.29
4.29
4.9
5.18
6.26
6.47
OPM %
19.45%
22.53%
22.22%
20.71%
20.37%
19.47%
18.8%
16.24%
Other Income
0
−0.45
0
0
0
0
0
0.01
Interest
0.01
0.01
0.05
0
0.07
0.06
0.06
0.05
Depreciation
0.08
0.08
0.12
0.13
0.1
0.17
0.19
0.22
PBT
3.22
3.77
4.12
4.16
4.73
4.95
6.01
6.21
Tax %
25.47%
25.46%
24.76%
25%
25.16%
25.05%
25.29%
27.05%
Net Profit
2.4
2.81
3.1
3.12
3.54
3.7
4.5
4.53
EPS (₹)
3.12
3.63
2.68
2.7
3.06
3.2
3.89
2.73

Profit & Loss

₹ Cr
543963 profit and loss, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
28.09
29.95
30.07
22.48
30.06
36.15
39.93
50.64
73.02
Expenses
27.94
30.65
29.83
22.29
27.01
28
31.14
40.57
60.29
Operating Profit
0.15
−0.7
0.24
0.19
3.05
8.15
8.79
10.07
12.73
OPM %
0.53%
−2.34%
0.8%
0.85%
10.15%
22.54%
22.01%
19.89%
17.43%
Other Income
0
0.83
0.01
0.01
0
−0.97
0
0.01
0.02
Interest
0
0
0.01
0.02
0.08
0.03
0.26
0.13
0.12
Depreciation
0.1
0.07
0.13
0.12
0.17
0.16
0.25
0.27
0.41
PBT
0.05
0.06
0.11
0.06
2.8
6.99
8.28
9.68
12.22
Tax %
20%
16.67%
27.27%
33.33%
26.79%
25.46%
25.12%
25.21%
26.19%
Net Profit
0.05
0.05
0.08
0.04
2.06
5.21
6.2
7.24
9.03
EPS (₹)
0.07
0.07
0.11
0.05
2.68
6.73
5.36
6.26
5.44
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
543963 balance sheet, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.45
0.45
0.45
0.48
0.48
7.74
11.56
11.56
16.61
Reserves
7.31
7.32
6.53
6.63
8.32
6.81
24.26
31.16
60.02
Borrowings
2.07
0.11
0.24
0
0.13
1.78
0.58
1.04
0.8
Other Liabilities
1.73
3.76
3.41
3.09
3.91
5.12
1.51
4.58
6.8
Total Liabilities
11.56
11.64
10.63
10.2
12.84
21.45
37.91
48.34
84.23
Fixed Assets
2.61
2.71
1.77
1.57
1.45
2.52
4.26
5.96
7.14
CWIP
0.14
0.11
0
0
0.55
0
0
0
0
Investments
0
0
0.68
0.68
0.68
0
0
0.68
0.68
Other Assets
8.81
8.82
8.18
7.95
10.16
18.93
33.65
41.7
76.41
Total Assets
11.56
11.64
10.63
10.2
12.84
21.45
37.91
48.34
84.23

Cash Flow

₹ Cr
543963 cash flow, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
0
−0.27
−0.28
0.52
0
−1.96
5.42
−12.48
Investing
—
0
0.29
0.03
−0.85
0.11
−4.43
−7.13
−14.55
Financing
—
0
0
0.48
0.06
0.21
11.01
0.09
24.69
Net Cash Flow
—
0
0.02
0.23
−0.27
0.33
4.61
−1.62
−2.34
Free Cash Flow
—
0
−0.32
−0.29
−0.08
0
−2.81
2.77
−14.07
CFO/EBITDA
—
0
−112
−147
17
0
−5
78
−73

Ratios

543963 financial ratios, annual
Particulars Mar 2016Mar 2017Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
12.99
14.14
7.4
12.34
19.55
82.69
80.9
68.26
59.03
Inventory Days
61.39
49.67
55.59
69.41
80.06
111
125
127
161
Days Payable
2.49
2.16
3.35
5.35
4.52
6.54
8.96
12.32
8.21
Cash Conversion Cycle
71.89
61.65
59.64
76.4
95.09
187
197
183
211
Working Capital Days
91.35
59.59
54.14
74.85
71.64
122
212
182
235
ROCE %
—
0.68%
—
1.12%
35.91%
63.26%
32.39%
24.48%
20.36%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Shelter Pharma insights

58 extracted metrics across FY16–FY26.

Shareholding Pattern

As of Sep 2026

  • Public 53.89%
  • Promoters 46.11%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Shelter Pharma

What does Shelter Pharma Ltd do?
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including food supplements for animals
Where is Shelter Pharma Ltd (SHELTER) listed?
Shelter Pharma Ltd trades under code 543963 on the BSE.
Which sector does Shelter Pharma Ltd belong to?
Shelter Pharma Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the 52-week high and low of Shelter Pharma Ltd?
Over the last 52 weeks Shelter Pharma Ltd has traded between ₹23 and ₹55.88 as of 4 Nov 2026.
Does Shelter Pharma Ltd pay dividends?
Shelter Pharma Ltd has a dividend yield of 0.75%.
What is the Return on Equity (ROE) of Shelter Pharma Ltd?
Shelter Pharma Ltd reported a return on equity of 15.10%. Its debt-to-equity ratio is 0.01.

Company Information

Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including food supplements for animals

Website shelter.co.in
Listed 23 Aug 2023
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543963.md for Shelter Pharma Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month